• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

COVID-19

Posted inClinical Trials, COVID-19, Infections

Upamostat: Oral Medication for COVID-19

by Mark Gubar March 3, 2022September 8, 2022

Upamostat by RedHill Biopharma prevents COVID-19 complications from developing followed by hospitalization or death.

Posted inClinical Trials, COVID-19, Infections, Oncology

Yeliva: New Drug for COVID-19

by Tanya von Reuss and Timur Burkhanayev February 19, 2022September 8, 2022

Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.

nurse
Posted inClinical Trials, COVID-19, Infections

MesenCure: Israeli Miracle Drug Saves From Death by COVID-19

by Mark Gubar January 25, 2022September 8, 2022

A cell therapy developed by Bonus BioGroup is amazingly able to fight coronavirus and its most severe complications.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, Research

Paxlovid Works Against Omicron

by Mark Gubar January 18, 2022September 8, 2022

The newest COVID-19 treatment is highly effective against the Omicron variant of SARS-CoV-2 coronavirus.

Posted inClinical Trials, COVID-19, Infections

Adintrevimab: Cure for All Mutant Variants of SARS-CoV-2

by Mark Gubar January 14, 2022September 8, 2022

Adagio Therapeutics’ monoclonal antibody will help fight all variants of the coronavirus.

Posted inClinical Trials, COVID-19, Infections

Ensovibep: Drug for All Variants of Coronavirus Including Omicron

by Mark Gubar January 10, 2022September 8, 2022

Molecular Partners and Novartis believe in the success of DARPins.

Posted inClinical Trials, COVID-19, Infections

Black Seed for Coronavirus Treatment

by Mark Gubar January 6, 2022September 8, 2022

Nigella sativa, or Prophetic medicine, as a possible cure for COVID-19.

Posts pagination

Newer posts 1 2 3 4 5 6 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×